Metformin augments the levels of molecules that regulate the expression of the insulin-dependent glucose transporter GLUT4 in the endometria of hyperinsulinemic PCOS patients

Human Reproduction

Volumn 28, Issue 8, 2013, Pages 2235-2244

  Carvajal, Rodrigo ^a   Rosas, Carlos ^a   Kohan, Karla ^a   Gabler, Fernando ^b   Vantman, David ^a   Romero, Carmen ^a   Vega, Margarita ^a  

^a HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

endometria; Glut4; insulin resistance; metformin; PCOS

Indexed keywords

ADENOSINE PHOSPHATE; ANDROGEN; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; METFORMIN; MYOCYTE ENHANCER FACTOR 2; PROTEIN KINASE; SEX HORMONE BINDING GLOBULIN; STEROID; TESTOSTERONE;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CELL SURFACE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM BIOPSY; ENZYME ACTIVE SITE; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PHOSPHORYLATION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEROID BLOOD LEVEL; WESTERN BLOTTING;

EID: 84880563304     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/det116     Document Type: Article

References (42)

1. Al-Khalili L, Forsgren M, Kannisto K, Zierath JR, Lönnqvist F, Krook A. Enhanced insulin-stimulated glycogen synthesis in response to insulin, metformin or rosiglitazone is associated with increased mRNA expression of GLUT4 and peroxisomal proliferator activator receptor gamma co-activator 1. Diabetologia 2005;48:1173-1179. (Pubitemid 40909654)
2. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE et al. Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006;91:4237-4245. (Pubitemid 44833391)
3. Bacallao K, Leon L, Gabler F, Soto E, Romero C, Valladares L, Vega M. In situ estrogen metabolism in proliferative endometria from untreated women with polycystic ovarian syndrome with and without endometrial hyperplasia. J Steroid Biochem Mol Biol 2008;110:163-169.
4. Diamanti-Kandarakis E. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications. Expert Rev Mol Med 2008; 10:e3.
5. Diamanti-Kandarakis E, Charikleia DC, Kandaraki E, Economou FN. Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome. Eur J Endocrinol 2010;162:193-212.
6. Fornés R, Ormazabal P, Rosas C, Gabler F, Vantman D, Romero C, Vega M. Changes in the expression of insulin signaling pathway molecules in endometria from polycystic ovary syndrome women with or without hyperinsulinemia. Mol Med 2010;16:129-136.
7. Giudice LC. Endometrium in PCOS: implantation and predisposition to endocrine cancer. Best Pract Res Clin Endocrinol Metab 2006; 20:235-244. (Pubitemid 43842928)
8. Glueck CJ, Ping W, Goldenberg N, Sieve-Smith L. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod 2002;17:2858-2864. (Pubitemid 35350902)
9. Hardie DG. The AMP-activated protein kinase pathway-new players upstream and downstream. J Cell Sci 2004;117:5479-5487. (Pubitemid 40012195)
10. Hawley S, Gadalla A, Olsen GS, Hardie DG. The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 2002; 51:2420-2425. (Pubitemid 34827390)
11. Holmes BF, Sparling DP, Olson AL, Winder WW, Dohm GL. Regulation of muscle GLUT4 enhancer factor and myocyte enhancer factor 2 by AMP-activated protein kinase. Am J Physiol Endocrinol Metab 2005; 289:E1071-E10716.
12. Jakubowicz DJ, Seppälä M, Jakubowicz S, Rodriguez-Armas O, Rivas-Santiago A, Koistinen H, Koistinen R, Nestler JE. Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome. J Clin Endocrinol Metab 2001;86:1126-1133. (Pubitemid 32322992)
13. Jensterle M, Janez A, Mlinar B, Marc J, Prezelj J, Pfeifer M. Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome. Eur J Endocrinol 2008;158:793-801. (Pubitemid 351837367)
14. Karlsson HK, Hällsten K, Björnholm M, Tsuchida H, Chibalin AV, Virtanen KA, Heinonen OJ, Lönnqvist F, Nuutila P, Zierath JR. Effects of metformin and rosiglitazone treatment on insulin signaling and glucose uptake in patients with newly diagnosed type 2 diabetes: a randomized controlled study. Diabetes 2005;54:1459-1467. (Pubitemid 40586678)
15. Karnieli E, Armoni M. Transcriptional regulation of the insulin-responsive glucose transporter GLUT4 gene: from physiology to pathology. Am J Physiol Endocrinol Metab 2008;295:E38-E45.
16. Kim JY, Song H, Kim H, Kang HJ, Jun JH, Hong SR, Koong MK, Kim IS. Transcriptional profiling with a pathway-oriented analysis identifies dysregulated molecular phenotypes in the endometrium of patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2009; 94:1416-1426.
17. Knight JB, Eyster CA, Griesel BA, Olson AL. Regulation of the human GLUT4 gene promoter: interaction between a transcriptional activator and myocyte enhancer factor 2A. Proc Natl Acad Sci USA 2003;100:14725-14730. (Pubitemid 37517958)
18. Kohan K, Carvajal R, Gabler F, Vantman D, Romero C, Vega M. Role of the transcriptional factors FOXO1 and PPARG on gene expression of SLC2A4 in endometrial tissue from women with polycystic ovary syndrome. Reproduction 2010;140:123-131.
19. Kola B, Boscaro M, Rutter GA, Grossman AB, Korbonits M. Expanding role of AMPK in endocrinology. Trends Endocrinol Metab 2006; 17:205-215. (Pubitemid 43974977)
20. Long YC, Zierath JR. AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest 2006;116:1776-1783. (Pubitemid 44033297)
21. Maliqueo M, Clementi M, Gabler F, Johnson M, Palomino A, Sir Peterman T, Vega M. Expression of steroid receptors and proteins related to apoptosis in endometria of women with polycystic ovary syndrome. Fertil Steril 2003;80:812-819. (Pubitemid 37152398)
22. McGee SL, Hargreaves M. Transporter isoform gene. Proceedings of the Australian Physiological Society Symposium: Integrative Aspects of Human Muscle Performance Exercise and skeletal muscle glucose transporter 4 expression: molecular mechanism. Clin Exp Pharmacol Physiol 2006;33:395-399.
23. Mioni R, Chiarelli S, Xamin N, Zuliani L, Granzotto M, Mozzanega B, Maffei P, Martini C, Blandamura S, Sicolo N et al. Evidence for the presence of glucose transporter 4 in the endometrium and its regulation in polycystic ovary syndrome patients. J Clin Endocrinol Metab 2004;59:4089-4096. (Pubitemid 39071517)
24. Mora S, Pessin JE. The MEF2A isoform is required for striated muscle-specific expression of the insulin-responsive GLUT4 glucose transporter. J Biol Chem 2000;275:16323-16328. (Pubitemid 30366948)
25. Morin-Papunen L, Rantala AS, Unkila-Kallio L, Tiitinen A, Hippelainen M, Perheentupa A, Tinkanen H, Bloigu R, Puukka K, Ruokonen A et al. Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial. J Clin Endocrinol Metab 2012; 97:1492-1500.
26. Mozzanega B, Mioni R, Granzotto M, Chiarelli S, Xamin N, Zuliani L, Sicolo N, Marchesoni D, Vettor R. Obesity reduces the expression of GLUT4 in the endometrium of normoinsulinemic women affected by the polycystic ovary syndrome. Ann N Y Acad Sci 2004;1034:364-374. (Pubitemid 40362374)
27. Murgia M, Jensen TE, Cusinato M, Garcia M, Richter E, Schiaffino S. Multiple signalling pathways redundantly control glucose transporter GLUT4 gene transcription in skeletal muscle. J Physiol 2009; 587:4319-4327.
28. Nestler JE. Metformin for the treatment of the polycystic ovary syndrome. N Engl J Med 2008;358:47-54.
29. Noyes R, Hertig A, Rock J. Dating the edometrial biopsy. Fertil Steril 1950; 1:3-5.
30. Palomba S, Russo T, Orio F Jr, Falbo A, Manguso F, Cascella T, Tolino A, Carmina E, Colao A, Zullo F. Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome. Hum Reprod 2006;21:457-465. (Pubitemid 43159923)
31. Palomba S, Falbo A, Zullo F, Orio F. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocr Rev 2009;30:1-50.
32. Rivero R, Garin C, Ormazabal P, Silva A, Carvajal R, Gabler F, Romero C, Vega M. Protein expression of PKCZ (protein kinase C Zeta), Munc18c, and Syntaxin-4 in the insulin pathway in endometria of patients with polycystic ovary syndrome (PCOS). Reprod Biol Endocrinol 2012;10:17.
33. Rosas C, Gabler F, Vantman D, Romero C, Vega M. Levels of Rabs and WAVE family proteins associated with translocation of GLUT4 to the cell surface in endometria from hyperinsulinemic PCOS women. Hum Reprod 2010;25:2870-2877.
34. Shaw RJ, Lamia K, Vasquez D, Seung-Hoi Koo, Bardeesy N, Depinho R, Montminy M, Cantley LC. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005;310:1642-1646. (Pubitemid 41780780)
35. Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, Dchiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev 2012:CD003053. doi:10.1002/14651858.CD00 3053.pub5.
36. Thai MV, Guruswamy S, Cao KT, Pessin JE, Olson AL. Myocyte enhancer factor 2 (MEF2)-binding site is required for GLUT4 gene expression in transgenic mice. Regulation of MEF2 DNA binding activity in insulin-deficient diabetes. J Biol Chem 1998;273:14285-14292. (Pubitemid 28319143)
37. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod 2004; 19:41-47.
38. Von Wolff M, Ursel S, Hahn U, Steldinger R, Strowitzki T. glucose transporter proteins (GLUT) in human endometrium: expression, regulation, and function throughout the menstrual cycle and in early pregnancy. J Clin Endocrinol Metab 2003;88:3885-3892. (Pubitemid 37034543)
39. Zhai J, Liu CX, Tian ZR, Jiang QH, Sun YP. Effects of metformin on the expression of GLUT4 in endometrium of obese women with polycystic ovary syndrome. Biol Reprod 2012;87:29.
40. Zhang L, Liao Q. Effects of testosterone and metformin on glucose metabolism in endometrium. Fertil Steril 2010;93:2295-2298.
41. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001;108:1167-1174. (Pubitemid 32995375)
42. Zorzano A, Palacín M, Gumà A. Mechanisms regulating GLUT4 glucose transporter expression and glucose transport in skeletal muscle. Acta Physiol Scand 2005;183:43-58. (Pubitemid 40188035) Tecnoló gico